Literature DB >> 10225405

Stevens-Johnson syndrome caused by indinavir.

R Teira1, Z Zubero, J Muñoz, J Baraia-Etxaburu, J M Santamaria.   

Abstract

A case is presented of an HIV-infected man who developed Stevens-Johnson syndrome shortly after the initiation of treatment with indinavir. This is the first case ever reported of this adverse drug reaction occurring with an HIV protease inhibitor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10225405     DOI: 10.1080/00365549850161322

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  2 in total

Review 1.  Indinavir: a review of its use in the management of HIV infection.

Authors:  G L Plosker; S Noble
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Inadvertent Provocative Oral Ondansetron use Leading to Toxic Epidermal Necrolysis in an HIV-infected Patient.

Authors:  Punit P Saraogi; Chitra S Nayak; Rickson R Pereira; Rachita S Dhurat
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.